Orion will publish Financial Statement Release for January-December 2020 on Tuesday, 9 February 2021 approximately at 12.00 noon EET. The release and related presentation material as well as link to live webcast and conference call info will be available here.
The 2021 Annual General Meeting of Orion Corporation is planned to be held on 25 March 2021 in Helsinki.
Orion Investor Relations have received several questions related to the coronavirus (COVID-19) pandemia and its impacts on Orion. We have listed here answers to some frequently asked questions.
The latest Corporate Governance Statement of Orion Corporation is available at the archive of Corporate Governance Statements.
|1/12/2021||Recommendation by the Nomination Committee concerning the Board of Directors to be elected by the 2021 AGM of Orion Corporation|
|12/18/2020||8,242 Orion Corporation A shares converted into B shares|
|10/29/2020||Prosecutor pressed charges against a member of Orion’s Board of Directors for a suspected securities market offence – the suspected offence is not related to Orion|
|10/21/2020||Composition of the Nomination Committee of Orion Corporation|
|1/20/2021||Orion publishes Financial Statement Release for 2020 on Tuesday 9 February 2021|
|1/18/2021||Orion Animal Health and Vetoquinol expand collaboration – Vetoquinol to distribute Orion’s Clevor® in the USA and Orion to distribute Drontal® and Profender® products in Finland, Hungary and Romania|
|11/10/2020||Orion invests EUR 17 million in its production plants in Turku|
|11/4/2020||Orion Research Foundation grants 1 014 400 euros for research in 2021|
Information about the price development of Orion's A and B shares. Also available a list of analysts covering Orion and the latest consensus estimate.
Orion Corporation has been included in the globally recognised FTSE4Good Index.
Research and development are Orion's strengths, and the company will continue to invest in them. The target is to increase net sales 1.5-fold by 2025.